(Q58289590)

English

Thromboembolism in Adults with Acute Lymphoblastic Leukemia During Induction with L-Asparaginase-containing Multi-agent Regimens: Incidence, Risk Factors, and Possible Role of Antithrombin

article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Thromboembolism in Adults with Acute Lymphoblastic Leukemia During Induction with L-Asparaginase-containing Multi-agent Regimens: Incidence, Risk Factors, and Possible Role of Antithrombin (English)

0 references

thromboembolism

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

7

object named as

Ayalew Tefferi

0 references

10

object named as

Mark R Litzow

0 references

author name string

Michelle A Elliott

1

0 references

Robert C Wolf

2

0 references

Christopher C Hook

3

0 references

Rajiv K Pruthi

4

0 references

John A Heit

5

0 references

Louis L Letendre

6

0 references

Scott H Kaufmann

8

0 references

Ruben A Mesa

9

0 references

publication date

August 2004

0 references

Leukemia & Lymphoma

0 references

45

0 references

8

0 references

1545-1551

0 references

Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001693588

21 January 2018

Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001693588

21 January 2018

A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001693588

21 January 2018

Antithrombin III during high-dose cytosine arabinoside therapy with or without asparaginase

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001693588

21 January 2018

Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001693588

21 January 2018

THROMBIN GENERATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: Effect of Leukemia Immunophenotypic Subgroups

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001693588

21 January 2018

Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001693588

21 January 2018

Uses of antithrombin III concentrate in congenital and acquired deficiency states

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001693588

21 January 2018

Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001693588

21 January 2018

Identifiers

10.1080/10428190410001693588

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58289590&oldid=2170679906"